Research Highlights

Gates Foundation Grant Jump-Starts Innovative Malaria Research at UT Austin

Posted on:

Exploring Entrepreneurship

Posted on:
Exploring Entrepreneurship

Texas ChE offered a new course this semester, ChE 379 Entrepreneurship, led by alumnus and established entrepreneur Michael Piana.

The elective introduces upperclassmen and graduate students to the basic concepts of entrepreneurship and the practical approaches of taking a business idea and monetizing it. Students of the course explore the keys to understanding the business … Read the rest »

Alumna Caitlin Spofford Discusses Her Texas ChE Research Experience

Posted on:

Anthrax Treatment Engineered by Texas ChE Researchers Gains FDA Approval

Posted on:
Anthrax Treatment Engineered by Texas ChE Researchers Gains FDA Approval

Researchers at The University of Texas at Austin, including Texas ChE’s Dr. George Georgiou and Dr. Jennifer Maynard, successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA). Part Read the rest »

FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Posted on:
FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student

Today the U.S. Food and Drug Administration approved the drug product Zepatier for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Texas ChE Ph.D. student Angela Wagner of Professor Nicholas Peppas’ research group was one of the team of eight researchers to co-invent and patent Zepatier.

Hepatitis … Read the rest »

Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Posted on:
Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials

Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »

Researchers Create a Nontoxic Flame Retardant

Posted on:
Researchers Create a Nontoxic Flame Retardant

Inspired by a naturally occurring material found in marine mussels, researchers in the McKetta Department of Chemical Engineering have created a new flame retardant to replace commercial additives that are often toxic and can accumulate over time in the environment and living animals, including humans.

Flame retardants are added to foams found in mattresses, sofas, … Read the rest »

New Institute Advances Health Care Solutions

Posted on:
New Institute Advances Health Care Solutions

The Cockrell School of Engineering at The University of Texas at Austin is launching the university’s first health care engineering institute dedicated to developing technologies and treatments that will immediately improve patient quality of life.

Led by Nicholas Peppas, a professor in the McKetta Department of Chemical Engineering, the College of Pharmacy, the Department … Read the rest »

Smarter Window Materials Can Control Light and Energy

Posted on:
Smarter Window Materials Can Control Light and Energy

Researchers in the Milliron Research Group at the McKetta Department of Chemical Engineering are one step closer to delivering smart windows with a new level of energy efficiency, engineering materials that allow windows to reveal light without transferring heat and, conversely, to block light while allowing heat transmission, as described in two new research papers.… Read the rest »

Peppas Named One of the Most Cited Researchers in World

Posted on: